Literature DB >> 25748931

Mesenchymal cell contributions to the stem cell niche.

Youmna Kfoury1, David T Scadden2.   

Abstract

Mesenchymal stromal cells (MSCs) are heterogeneous and primitive cells discovered first in the bone marrow (BM). They have putative roles in maintaining tissue homeostasis and are increasingly recognized as components of stem cell niches, which are best defined in the blood. The absence of in vivo MSC markers has limited our ability to track their behavior in vivo and draw comparisons with in vitro observations. Here we review the historical background of BM-MSCs, advances made in their prospective isolation, their developmental origin and contribution to maintaining subsets of hematopoietic cells, and how mesenchymal cells contribute to other stem cell niches.
Copyright © 2015 Elsevier Inc. All rights reserved.

Mesh:

Substances:

Year:  2015        PMID: 25748931     DOI: 10.1016/j.stem.2015.02.019

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  180 in total

1.  Prospective isolation of resident adult human mesenchymal stem cell population from multiple organs.

Authors:  Yo Mabuchi; Yumi Matsuzaki
Journal:  Int J Hematol       Date:  2015-12-16       Impact factor: 2.490

Review 2.  The aging hematopoietic stem cell niche: Phenotypic and functional changes and mechanisms that contribute to hematopoietic aging.

Authors:  Sarah E Latchney; Laura M Calvi
Journal:  Semin Hematol       Date:  2016-10-19       Impact factor: 3.851

3.  A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia.

Authors:  Ninib Baryawno; Dariusz Przybylski; Monika S Kowalczyk; Youmna Kfoury; Nicolas Severe; Karin Gustafsson; Konstantinos D Kokkaliaris; Francois Mercier; Marcin Tabaka; Matan Hofree; Danielle Dionne; Ani Papazian; Dongjun Lee; Orr Ashenberg; Ayshwarya Subramanian; Eeshit Dhaval Vaishnav; Orit Rozenblatt-Rosen; Aviv Regev; David T Scadden
Journal:  Cell       Date:  2019-05-23       Impact factor: 41.582

Review 4.  Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities.

Authors:  Jacques Galipeau; Luc Sensébé
Journal:  Cell Stem Cell       Date:  2018-06-01       Impact factor: 24.633

5.  Long-term survival of donor bone marrow multipotent mesenchymal stromal cells implanted into the periosteum of patients with allogeneic graft failure.

Authors:  L A Kuzmina; N A Petinati; N V Sats; N J Drize; N V Risinskaya; A B Sudarikov; V A Vasilieva; M Y Drokov; E D Michalzova; E N Parovichnikova; V G Savchenko
Journal:  Int J Hematol       Date:  2016-05-12       Impact factor: 2.490

6.  BMP Signaling in Regulating Mesenchymal Stem Cells in Incisor Homeostasis.

Authors:  C Shi; Y Yuan; Y Guo; J Jing; T V Ho; X Han; J Li; J Feng; Y Chai
Journal:  J Dent Res       Date:  2019-05-28       Impact factor: 6.116

Review 7.  Gene therapy using haematopoietic stem and progenitor cells.

Authors:  Giuliana Ferrari; Adrian J Thrasher; Alessandro Aiuti
Journal:  Nat Rev Genet       Date:  2020-12-10       Impact factor: 53.242

8.  Snail/Slug-YAP/TAZ complexes cooperatively regulate mesenchymal stem cell function and bone formation.

Authors:  Yi Tang; Stephen J Weiss
Journal:  Cell Cycle       Date:  2017-01-23       Impact factor: 4.534

9.  Mesenchymal Stem Cell-Derived Exosomes: New Opportunity in Cell-Free Therapy.

Authors:  Davod Pashoutan Sarvar; Karim Shamsasenjan; Parvin Akbarzadehlaleh
Journal:  Adv Pharm Bull       Date:  2016-09-25

10.  EBF1-deficient bone marrow stroma elicits persistent changes in HSC potential.

Authors:  Marta Derecka; Josip Stefan Herman; Pierre Cauchy; Senthilkumar Ramamoorthy; Ekaterina Lupar; Dominic Grün; Rudolf Grosschedl
Journal:  Nat Immunol       Date:  2020-02-17       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.